Ten current research findings on retatrutide, from weight loss and liver fat to blood sugar and sleep apnoea, with sources and limits for anyone considering a future treatment change.

Ten current research findings on retatrutide, from weight loss and liver fat to blood sugar and sleep apnoea, with sources and limits for anyone considering a future treatment change.
Explore 20 evidence-based GLP-1 tips for eating well, managing common side effects, preserving muscle and discussing treatment with your Canadian healthcare team.

Evidence checked: September 15, 2026. Tirzepatide vs eloralintide vs mazdutide is a study comparison. No trial has tested all three against each other. Researchers studied each one in a different group of people. This guide keeps those results separate so the numbers stay clear. Tirzepatide has the largest and longest published trial of the three. […]

Compare BAC Water and sterile water, 0.9% benzyl alcohol, Canadian and U.S. labels, refrigeration guidance and the limits of 28-day stability claims.

Retatrutide research through September 2026: published Phase 3 data, TRIUMPH results, study limitations and Canadian approval status, with primary sources.

CJC-1295 vs Ipamorelin compared: GHRH vs GHRP mechanisms, DAC vs No-DAC, combined research rationale, safety limitations, and Canadian sourcing.

Compare GHK-Cu and BPC-157 by structure, mechanism, evidence quality, and laboratory context without human-use or treatment claims.

Confused about peptide legality in Canada? This guide walks through Health Canada’s Food and Drugs Act framework and recent enforcement, sourced and current.

Compare tirzepatide and retatrutide receptor targets, clinical evidence, the ongoing head-to-head trial and Canadian status. Reviewed September 2026.

Sermorelin vs CJC-1295 compared: mechanism, half-life, and peer-reviewed evidence for Canadian researchers. Read the neutral, citation-backed guide today.